1. Home
  2. ARE vs ABVX Comparison

ARE vs ABVX Comparison

Compare ARE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexandria Real Estate Equities Inc.

ARE

Alexandria Real Estate Equities Inc.

HOLD

Current Price

$52.42

Market Cap

9.1B

Sector

Real Estate

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$114.21

Market Cap

10.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARE
ABVX
Founded
1994
2013
Country
United States
France
Employees
N/A
67
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
10.5B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
ARE
ABVX
Price
$52.42
$114.21
Analyst Decision
Hold
Buy
Analyst Count
11
12
Target Price
$58.78
$128.42
AVG Volume (30 Days)
1.8M
724.1K
Earning Date
04-27-2026
01-01-0001
Dividend Yield
8.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,026,556,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.52
$0.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.10
$4.77
52 Week High
$105.14
$148.83

Technical Indicators

Market Signals
Indicator
ARE
ABVX
Relative Strength Index (RSI) 44.67 43.01
Support Level $49.38 $107.99
Resistance Level $54.86 $131.27
Average True Range (ATR) 1.73 4.96
MACD -0.18 -1.40
Stochastic Oscillator 50.43 32.31

Price Performance

Historical Comparison
ARE
ABVX

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: